Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 5.96% · OPTIONAL
· Services-Commercial Physical & Biological Research
RESEARCH SNAPSHOTbioAffinity Technologies, Inc.'s latest supported as-filed period reports revenue of $1.5M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 5.96% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -211.91% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 18.99% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 5.45% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value -220.77% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 23.94% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Capital expenditure increased 570.1%; Capex / revenue moved 490 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 19.0%; Operating margin moved 2261 bp lower; Operating income decreased 32.6%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 87.3%; Inventory / revenue moved 199 bp higher.
2 evidence-backed componentsCapital expenditure changed +570.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
BIAF · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-042304SEC ↗8-KSep 9, 2026Period Sep 8, 20260001493152-26-041894SEC ↗8-KSep 3, 2026Period Sep 3, 20260001493152-26-041387SEC ↗8-KSep 1, 2026Period Sep 1, 20260001493152-26-041020SEC ↗8-KAug 20, 2026Period Aug 20, 20260001493152-26-039375SEC ↗8-KAug 18, 2026Period Aug 18, 20260001493152-26-038897SEC ↗8-KAug 14, 2026Period Aug 12, 20260001493152-26-038437SEC ↗10-QTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jan 10, 2025Filed Jan 14, 2025 | Reveles Xavier TrinidadChief Operating Officer | Grant Or AwardDirect | 21,604 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 51.96% · OPTIONAL
Operating income changed -32.6% from the comparable as-filed period.
Total assets changed +60.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -23.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -2261 basis points from the comparable as-filed period.
Operating cash flow changed -20.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed +202.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-036619